<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Eur J Hum Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">Eur. J. Hum. Genet</journal-id>
<journal-title-group>
<journal-title>European Journal of Human Genetics</journal-title>
</journal-title-group>
<issn pub-type="ppub">1018-4813</issn>
<issn pub-type="epub">1476-5438</issn>
<publisher>
<publisher-name>Springer International Publishing</publisher-name>
<publisher-loc>Cham</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30258123</article-id>
<article-id pub-id-type="pmc">6303265</article-id>
<article-id pub-id-type="publisher-id">272</article-id>
<article-id pub-id-type="doi">10.1038/s41431-018-0272-6</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>A weighted burden test using logistic regression for integrated analysis of sequence variants, copy number variants and polygenic risk score</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Curtis</surname>
<given-names>David</given-names>
</name>
<address>
<email>d.curtis@ucl.ac.uk</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2171 1133</institution-id><institution-id institution-id-type="GRID">grid.4868.2</institution-id><institution>Centre for Psychiatry, </institution><institution>Barts and the London School of Medicine and Dentistry, Charterhouse Square, </institution></institution-wrap>London, EC1M 6BQ UK </aff>
<aff id="Aff2"><label>2</label>UCL Genetics Institute, UCL, Darwin Building, Gower Street, London, WC1E 6BT UK </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>26</day>
<month>9</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<month>1</month>
<year>2019</year>
</pub-date>
<volume>27</volume>
<issue>1</issue>
<fpage>114</fpage>
<lpage>124</lpage>
<history>
<date date-type="received">
<day>22</day>
<month>4</month>
<year>2018</year>
</date>
<date date-type="rev-recd">
<day>15</day>
<month>8</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>30</day>
<month>8</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>© European Society of Human Genetics 2018</copyright-statement>
</permissions>
<abstract id="Abs1">
<p id="Par1">Previously described methods of analysis allow variants in a gene to be weighted more highly according to rarity and/or predicted function and then for the variant contributions to be summed into a gene-wise risk score, which can be compared between cases and controls using a <italic>t</italic>-test. However, this does not allow incorporating covariates into the analysis. Schizophrenia is an example of an illness where there is evidence that different kinds of genetic variation can contribute to risk, including common variants contributing to a polygenic risk score (PRS), very rare copy number variants (CNVs) and sequence variants. A logistic regression approach has been implemented to compare the gene-wise risk scores between cases and controls, while incorporating as covariates population principal components, the PRS and the presence of pathogenic CNVs and sequence variants. A likelihood ratio test is performed, comparing the likelihoods of logistic regression models with and without this score. The method was applied to an ethnically heterogeneous exome-sequenced sample of 6000 controls and 5000 schizophrenia cases. In the raw analysis, the test statistic is inflated but inclusion of principal components satisfactorily controls for this. In this dataset, the inclusion of the PRS and effect from CNVs and sequence variants had only small effects. The set of genes which are <italic>FMRP</italic> targets showed some evidence for enrichment of rare, functional variants among cases (<italic>p</italic> = 0.0005). This approach can be applied to any disease in which different kinds of genetic and non-genetic risk factors make contributions to risk.</p>
</abstract>
<kwd-group kwd-group-type="npg-subject">
<title>Subject terms</title>
<kwd>Risk factors</kwd>
<kwd>Genome-wide association studies</kwd>
</kwd-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© European Society of Human Genetics 2019</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
</article>
</pmc-articleset>